Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents: an observational cohort study.

Garelius HKG, Bagguley T, Taylor A, Fenaux P, Bowen D, Symeonidis A, Mittelmann M, Stauder R, Čermák J, Sanz G, Langemeijer S, Malcovati L, Germing U, Sanhes L, d'Aveni M, Culligan D, Kotsianidis I, Koinig KA, van Marrewijk C, Crouch S, deWitte T, Smith A, Hellström-Lindberg E

Open source

DOI: 10.1016/s2352-3026(24)00350-8
Published: 2025 Feb
Container: The Lancet. Haematology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2352-3026-24-00350-8,
  title = {Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents: an observational cohort study.},
  author = {Garelius HKG and Bagguley T and Taylor A and Fenaux P and Bowen D and Symeonidis A and Mittelmann M and Stauder R and Čermák J and Sanz G and Langemeijer S and Malcovati L and Germing U and Sanhes L and d'Aveni M and Culligan D and Kotsianidis I and Koinig KA and van Marrewijk C and Crouch S and deWitte T and Smith A and Hellström-Lindberg E},
  year = {2025},
  journal = {The Lancet. Haematology},
  doi = {10.1016/s2352-3026(24)00350-8},
  url = {https://doi.org/10.1016/s2352-3026(24)00350-8}
}

RIS

TY  - JOUR
TI  - Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents: an observational cohort study.
AU  - Garelius HKG
AU  - Bagguley T
AU  - Taylor A
AU  - Fenaux P
AU  - Bowen D
AU  - Symeonidis A
AU  - Mittelmann M
AU  - Stauder R
AU  - Čermák J
AU  - Sanz G
AU  - Langemeijer S
AU  - Malcovati L
AU  - Germing U
AU  - Sanhes L
AU  - d'Aveni M
AU  - Culligan D
AU  - Kotsianidis I
AU  - Koinig KA
AU  - van Marrewijk C
AU  - Crouch S
AU  - deWitte T
AU  - Smith A
AU  - Hellström-Lindberg E
PY  - 2025
JO  - The Lancet. Haematology
DO  - 10.1016/s2352-3026(24)00350-8
UR  - https://doi.org/10.1016/s2352-3026(24)00350-8
ER  -

APA

HKG, G., T, B., A, T., P, F., D, B., A, S., M, M., R, S., J, Č., G, S., S, L., L, M., U, G., L, S., M, D., D, C., I, K., KA, K., C, V. M., S, C., T, D., A, S., & E, H. (2025). Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents: an observational cohort study.. The Lancet. Haematology. https://doi.org/10.1016/s2352-3026(24)00350-8

Source records

pubmed · retrieved 2026-09-26T12:37:19.356Z